Steadybase.

Canopy Growth Corp.

Website LinkedIn Latest 10-K
  • CGC · Nasdaq
  • Medicinal Chemicals & Botanical Products
  • Smith Falls, A6
  • 1,128 employees
  • CIK 0001737927

Updated from SEC filings through

Top things to know

Executives

Canopy Growth Corp is a U.S. public company in medicinal chemicals & botanical products (SIC 2833), headquartered in Smith Falls, A6. It trades as CGC on Nasdaq. It reported about 1,128 employees. Luc Mongeau is Chief Executive Officer.

Five-year financials

We have no annual financials for this company yet.

Annual figures from XBRL in each company's own filings. Click a figure to open the filing. SG&A marked derived is general and administrative plus selling and marketing.

Leadership and board

NameTitleSource
Luc Mongeau Luc Mongeau
C-Suite Leader | Transformational Leadership |
Chief Executive Officer Form 4, June 22, 2026
Thomas Stewart Named in proxy
bio: CFO
DEF 14A, August 7, 2026
Christelle Gedeon Christelle Gedeon Chief Business Development & Corporate Affairs Officer 10-K, June 15, 2026
M. Shan Atkins Board member (per proxy)
bio: Director
DEF 14A, August 7, 2026

What Canopy Growth Corp does

Committed to Bettering Lives Through Cannabis For the patient finding relief, the person rediscovering balance, the consumer who expects better.

Company website description, 10-K for the year ending November 7, 2026

Shares and governance

Shares outstanding 423.4 million (as of November 4, 2026) 10-Q, November 6, 2026
Public float $485M (as of September 30, 2025) 10-K, June 15, 2026
Reportable segments 2 (period ending September 30, 2026) 10-Q, November 6, 2026
Latest proxy statement Meeting September 25, 2026 (filed August 7, 2026) DEF 14A, August 7, 2026
Auditor PKF O’Connor Davies, LLP (New York, New York) Latest 10-K

Insider trades

Open-market buys and sales by officers and directors, from Forms 4 and 5. One row per filing.

DateInsiderTradeSharesValueSource
September 28, 2026 Theresa Yanofsky
Director
Sale 14,920 $14K Form 4, September 30, 2026
September 28, 2026 David Angelo Lazzarato
Director
Sale 22,380 $21K Form 4, September 30, 2026
September 28, 2026 Joseph Bayern
Director
Sale 3,096 $3K Form 4, September 30, 2026
September 28, 2026 M. Shan Atkins
Director
Sale 3,096 $3K Form 4, September 30, 2026
September 17, 2026 Thomas Carlton Stewart
See Remarks
Sale 25,755 $24K Form 4, September 17, 2026
August 24, 2026 Christelle Gedeon
See Remarks
Sale 13,344 $20K Form 4, August 25, 2026
August 24, 2026 Thomas Carlton Stewart
See Remarks
Sale 2,231 $3K Form 4, August 25, 2026
June 26, 2026 Joseph Bayern
Director
Sale 3,197 $3K Form 4, June 29, 2026

Recent 8-K events

Frequently asked questions about Canopy Growth Corp

What does Canopy Growth Corp do?
In its own words, from Item 1 of its 10-K: "Committed to Bettering Lives Through Cannabis For the patient finding relief, the person rediscovering balance, the consumer who expects better."
How many employees does Canopy Growth Corp have?
About 1,128 as of March 31, 2026, as stated in its annual report.
Who is the CEO of Canopy Growth Corp?
Luc Mongeau, Chief Executive Officer, as named in a 4 filed June 22, 2026.
Where is Canopy Growth Corp headquartered?
Smith Falls, A6.
What is Canopy Growth Corp's stock ticker?
CGC on Nasdaq.
What industry is Canopy Growth Corp in?
Medicinal Chemicals & Botanical Products, SIC code 2833.
What is Canopy Growth Corp's website?
canopygrowth.com.
When does Canopy Growth Corp report earnings next?
February 5, 2027. This is an estimate from past filing dates, not a confirmed date.
Is Canopy Growth Corp a public company?
Yes. Canopy Growth Corp files with the SEC under CIK 0001737927 and trades as CGC.
Who audits Canopy Growth Corp?
PKF O’Connor Davies, LLP, New York, New York, as named in its latest annual report (10-K).
How many shares of Canopy Growth Corp are outstanding?
423.4 million shares as of November 4, 2026, from its 10-Q filed November 6, 2026.
What is Canopy Growth Corp's public float?
$485M as of September 30, 2025, as reported on the cover of its 10-K filed June 15, 2026.
How many business segments does Canopy Growth Corp report?
2 reportable segments for the period ending September 30, 2026, from its 10-Q filed November 6, 2026.
When is Canopy Growth Corp's annual shareholder meeting?
September 25, 2026, per its proxy statement (DEF 14A) filed August 7, 2026.
Have Canopy Growth Corp insiders traded stock recently?
Since June 30, 2025, officers and directors reported 31 open-market sales worth about $548K and 1 purchase worth about $50K on Forms 4 and 5. The most recent: Theresa Yanofsky (Director) sold 14,920 shares on September 28, 2026.